Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz
Despite their incredible contribution to fighting viral infections, antiviral viral resistance is an increasing concern and often arises due to unfavorable physicochemical and biopharmaceutical properties. To address this kind of issue, lipid nanocapsules (LNC) are developed in this study, using efa...
Main Authors: | Grady K. Mukubwa, Justin B. Safari, Roderick B. Walker, Rui W. M. Krause |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/7/1318 |
Similar Items
-
Biological response and cytotoxicity induced by lipid nanocapsules
by: Marzena Szwed, et al.
Published: (2020-01-01) -
Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01) -
Lipid core nanocapsules-loaded tacrolimus: Development and evaluation of quality parameters
by: Graziela Scheuer Gomes, et al.
Published: (2022-07-01) -
Efavirenz and neuropsychiatric effects
by: Mukesh Dheda
Published: (2017-04-01) -
Short Term Stability Testing of Efavirenz-Loaded Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carrier (NLC) Dispersions
by: Pedzisai A. Makoni, et al.
Published: (2019-08-01)